Ultragenyx Germany GmbH

Name: Ultragenyx Germany GmbH
Address: Rahel-Hirsch-Str. 10, Berlin, Berlin, 10557, DE
Telephone: 068215016170

Pharmaceutical Companies · Berlin

Ultragenyx Germany GmbH is the German subsidiary of US-amerikanischen Biotechnologieunternehmens Ultragenyx Pharmaceutical Inc, based in Berlin.

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Ultragenyx Germany GmbH – Address & Contact

Phone

Website

Email

Address

Rahel-Hirsch-Str. 10
10557 Berlin

Ultragenyx Germany GmbH Overview

Ultragenyx Germany GmbH is a pharmaceutical company based in Berlin, Berlin. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Ultragenyx Germany GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

About Ultragenyx Germany GmbH

We develop medicines for patients with rare diseases.

Location & Contact

Ultragenyx Germany GmbH can be reached at the following address: Rahel-Hirsch-Str. 10, 10557 Berlin – Phone: 068215016170. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Berlin or all Pharmaunternehmen in Germany on Sanoliste.

Frequently asked questions about Ultragenyx Germany GmbH

What does Ultragenyx Germany GmbH do?

Das Arattsgebiet of Ultragenyx Germany GmbH is the Erforschen seltener, erblich bedingter Krankheiten. Dazu gehören z.B. Morbus Sly, Morbus Cori and Morbus Wilson. Ultragenyx develops verschiedene Therapien with underschiedlichen Medikamenten. Zum Einsatz kommen traditionelle Biologika, Gentherapien or Nukleinsäuretherapien. Außerdem hat Ultragenyx the developmentsverfahren for Medikamente beschleunigt.